These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24535159)

  • 1. Finding suitable targets is the major obstacle to cancer gene therapy.
    Rosenberg SA
    Cancer Gene Ther; 2014 Feb; 21(2):45-7. PubMed ID: 24535159
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional Infusion of Chimeric Antigen Receptor T Cells to Overcome Barriers for Solid Tumor Immunotherapy.
    Hardaway JC; Prince E; Arepally A; Katz SC
    J Vasc Interv Radiol; 2018 Jul; 29(7):1017-1021.e1. PubMed ID: 29935783
    [No Abstract]   [Full Text] [Related]  

  • 3. Adoptive cell therapy: Honing that killer instinct.
    Humphries C
    Nature; 2013 Dec; 504(7480):S13-5. PubMed ID: 24352359
    [No Abstract]   [Full Text] [Related]  

  • 4. Adoptive cell transfer of T-cell receptor-engineered lymphocytes: lessons from recent modeling.
    Ribas A; Koya RC
    Future Oncol; 2010 Nov; 6(11):1671-3. PubMed ID: 21142653
    [No Abstract]   [Full Text] [Related]  

  • 5. Adoptive transfer of virus-specific and tumor-specific T cell immunity.
    Berger C; Turtle CJ; Jensen MC; Riddell SR
    Curr Opin Immunol; 2009 Apr; 21(2):224-32. PubMed ID: 19304470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-targeting T-cells against cancer by gene-transfer of tumor-reactive receptors.
    Marcu-Malina V; van Dorp S; Kuball J
    Expert Opin Biol Ther; 2009 May; 9(5):579-91. PubMed ID: 19368527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric T-cell receptors for the targeting of cancer cells.
    Rössig C; Brenner MK
    Acta Haematol; 2003; 110(2-3):154-9. PubMed ID: 14583676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promise and potential pitfalls of chimeric antigen receptors.
    Sadelain M; Brentjens R; Rivière I
    Curr Opin Immunol; 2009 Apr; 21(2):215-23. PubMed ID: 19327974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptor gene-modified cells: past promises, present methodologies and future challenges.
    Tendeiro Rego R; Morris EC; Lowdell MW
    Cytotherapy; 2019 Mar; 21(3):341-357. PubMed ID: 30655164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive transfer of T-cell immunity.
    Kessels HW; Wolkers MC; Schumacher TN
    Trends Immunol; 2002 May; 23(5):264-9. PubMed ID: 12102748
    [No Abstract]   [Full Text] [Related]  

  • 11. Chimeric Antigen Receptor Therapy.
    June CH; Sadelain M
    N Engl J Med; 2018 Jul; 379(1):64-73. PubMed ID: 29972754
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects.
    Di S; Li Z
    Sci China Life Sci; 2016 Apr; 59(4):360-9. PubMed ID: 26968709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive T-cell therapy for cancer: The era of engineered T cells.
    Bonini C; Mondino A
    Eur J Immunol; 2015 Sep; 45(9):2457-69. PubMed ID: 26202766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy.
    Zhang X; Cheng C; Sun W; Wang H
    Methods Mol Biol; 2020; 2115():419-433. PubMed ID: 32006414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redirected T cells in cancer therapy.
    Sangiolo D
    Expert Opin Biol Ther; 2015; 15(12):1667-70. PubMed ID: 26515608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing T-cell receptor gene therapy for hematologic malignancies.
    Morris EC; Stauss HJ
    Blood; 2016 Jun; 127(26):3305-11. PubMed ID: 27207802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CAR T-cell therapy in refractory large B-cell lymphoma.
    Stirrups R
    Lancet Oncol; 2018 Jan; 19(1):e19. PubMed ID: 29249304
    [No Abstract]   [Full Text] [Related]  

  • 18. Minicircle-Based Engineering of Chimeric Antigen Receptor (CAR) T Cells.
    Hudecek M; Gogishvili T; Monjezi R; Wegner J; Shankar R; Kruesemann C; Miskey C; Ivics Z; Schmeer M; Schleef M
    Recent Results Cancer Res; 2016; 209():37-50. PubMed ID: 28101686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Armed T cells with CAR for cancer immunotherapy.
    Wei YQ
    Sci China Life Sci; 2016 Apr; 59(4):331-2. PubMed ID: 27080712
    [No Abstract]   [Full Text] [Related]  

  • 20. CAR T cell immunotherapy for human cancer.
    June CH; O'Connor RS; Kawalekar OU; Ghassemi S; Milone MC
    Science; 2018 Mar; 359(6382):1361-1365. PubMed ID: 29567707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.